Polydatin ameliorates hyperhidrosis by targeting Aqp5 in a mouse model

Polydatin alleviates hyperhidrosis by targeting AQP5 and suppressing key neurologic factors, supporting its potential as a novel therapeutic approach for PFH.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2025-08-13
DOI
https://doi.org/10.3389/fphar.2025.1589143
Primary Topic
Sympathectomy and Hyperhidrosis Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Polydatin ameliorates hyperhidrosis by targeting Aqp5 in a mouse model

Feng Zhi, Runze Qiu, Jianbo Lin, Fangqun Yu et al.
Frontiers in Pharmacology
Sympathectomy and Hyperhidrosis Treatments
article

Polydatin ameliorates hyperhidrosis by targeting Aqp5 in a mouse model

Feng Zhi, Runze Qiu, Jianbo Lin, Fangqun Yu, Jian-Feng Chen, Xu Li
article en

Abstract

Polydatin alleviates hyperhidrosis by targeting AQP5 and suppressing key neurologic factors, supporting its potential as a novel therapeutic approach for PFH.

Frontiers in PharmacologyVol. 16
Fujian Medical University (CN), First Affiliated Hospital of Fujian Medical University (CN)
Openalex Percentile: Top 74%
Sympathectomy and Hyperhidrosis Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Polydatin ameliorates hyperhidrosis by targeting Aqp5 in a mouse model — Feng Zhi, Runze Qiu, et al. · Frontiers in Pharmacology (2025) | TGRS Research Map | TGRS